North America And Europe Stroke Diagnostics Market To Reach $3.53 Billion By 2030

North America And Europe Stroke Diagnostics Market Growth & Trends

The North America And Europe stroke diagnostics market size is projected to reach USD 3.53 billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising geriatric population in countries like U.S. and Germanyhas led to high growth of the market. Geriatric population in U.S. is anticipated to rise to around 98 million by 2060.

Unhealthy lifestyle is another significant factor driving demand for stroke diagnostic products. Unhealthy lifestyles and physical inactivity are attributed to rising cases of diabetes, obesity, and other such health conditions. According to the Centers for Disease Control and Prevention (CDC) 2017 statistics, over 36% of U.S. population is obese. Diabetes is also one of the prevalent health conditions in Europe. Thus, increasing incidence of such disease conditions has propelled the market for stroke diagnostics.

Rise in awareness among people pertaining to stroke diagnosis and treatment is also expected to foster market growth. In 2011, the Department of Health and Human Services in U.S. started the Million Hearts program as an initiative to avert strokes by 2017. Building on the experience of the first five years the program is committed to work towards prevention of 1 million strokes. The program aims at taking steps to prevent cardiovascular diseases, such as strokes and improving overall public health. Such awareness programs undertaken by government are likely to boost the market growth.

 Request a free sample copy or view report summary: North America And Europe Stroke Diagnostics Market Report

North America And Europe Stroke Diagnostics Market Report Highlights

• Computed Tomography Scan (CT scan) dominated the market and accounted for a share of 52.5% in 2023. This is owing to the availability of noninvasive diagnostic techniques and accurate results. 

• Carotid ultrasound (CUS) is expected to register the fastest CAGR of 9.6% during the forecast period. CUS uses sound waves to show the carotid arteries. 

• North America stroke diagnosis market dominated the market in 2023 with a share of 59.6%. The National Stroke Association highlights that stroke is the fifth-leading cause of death in the U.S. 

• Asia Pacific stroke diagnostics market is anticipated to witness significant growth in coming years. The growth is fueled by a substantial and expanding population that is susceptible to stroke and an increasing expenditure on healthcare.

North America And Europe Stroke Diagnostics Market Segmentation

Grand View Research has segmented the North America and Europe stroke diagnostics market report based on product and region:

North America And Europe Stroke Diagnostics Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Magnetic Resonance Imaging (MRI)

• Computed Tomography Scan (CT Scan)

• Carotid Ultrasound

• Cerebral Angiography

• Nuclear Imaging

• Others

North America And Europe Stroke Diagnostics Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

List Of Key Players in the North America And Europe Stroke Diagnostics Market

• Siemens Healthineers AG

• Cordis.

• Boston Scientific Corporation

• GE HealthCare

• Koninklijke Philips N.V.

• TOSHIBA CORPORATION

• Hitachi High-Tech Corporation

• Neusoft Corporation